PharmaShots

MAY 19, 2023

Alimera Acquires Rights from EyePoint Pharmaceuticals to Commercialise Yutiq in the US Date: May 19, 2023 | Tags: Alimera, EyePoint Pharmaceuticals, Yutiq, Iluvien, chronic non-infectious uveitis, US, Pharma Sobi Reports EMA’s Validation of MAA for Efanesoctocog Alfa to Treat Haemophilia A Date: May 19, 2023 | Tags: Sobi, Efanesoctocog Alfa, (..)

Medical Schools 40

Medical Schools Biosimilars Immunity Immunization 40

pharmaphorum

DECEMBER 17, 2020

Her videos cover a host of topics from the science behind the immune system, side effects caused by the shots and vaccine hesitancy and the clinical and regulatory path to approval. Additionally, we will soon introduce a new vaccine tag to detect and tag all videos with words and hashtags related to the COVID-19 vaccine,” says Morgan. “We

Vaccines 89

Vaccines Communication Immunity Immunization 89

pharmaphorum

JANUARY 18, 2022

Two Spanish pharma companies are joining forces to identify new oral treatments for immune-inflammatory skin diseases with high unmet medical needs. Researchers at Almirall have identified several proteins whose abnormal function is associated with inflammatory immune skin diseases.

Immunity 52

Immunity Immunization Drug Development 52

Pharmaceutical Technology

MAY 2, 2023

IO agents include the classes of immune checkpoint modulators, cell therapies, bispecific antibodies, oncolytic viruses, therapeutic vaccines, and cytokines. IO therapies come with a hefty price tag, with ICI therapies in the US typically exceeding $100,000, while cell therapies can exceed $400,000.

Immunity 52

Immunity Immunization Vaccines 52

pharmaphorum

DECEMBER 12, 2022

Dutch biotech Argenx is on course to add another rare disease indication to the label of its FcRn blocker Vyvgart – primary immune thrombocytopenia (ITP) – thanks to new data reported at the ASH annual meeting.

Immunity 52

Immunity Immunization Labelling 52

pharmaphorum

AUGUST 25, 2022

The double-headed antibody binds to CD3 on T cells and redirects them to BCMA-expressing myeloma cells, with the aim of stimulating an immune attack on the tumour, which remains incurable despite a slew of new therapies reaching the market in recent years.

Immunity 98

Immunity Immunization 98

Pharmaceutical Technology

DECEMBER 5, 2022

CB1 receptors are primarily expressed in the brain and central nervous system, whereas CB2 receptors are expressed in T-cells in the immune system. Collectively, cannabinoid receptors (CB1 and CB2) are currently the most popular targets in preclinical stage of development, with 391 drugs tagged in total.

Controlled Substances 98

Controlled Substances Compounding Immunity Immunization 98

pharmaphorum

APRIL 5, 2022

The one-year survival rate with the drug was 73%, compared to 58% in a group receiving standard-of-care – off-label immune checkpoint inhibitors used for other forms of melanoma like Merck & Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Yervoy (ipilimumab) or chemotherapy with dacarbazine.

Labelling 52

Labelling Chemotherapy Immunity Immunization 52

pharmaphorum

DECEMBER 23, 2022

In the last few years, the first generation of cell therapies has offered a powerful new way of treating blood cancers, with CAR-T technology reprogramming patients’ immune system to fight cancer. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Drug Development 52

Drug Development Immunity Immunization Hospitals 52

pharmaphorum

FEBRUARY 22, 2021

Lentiviral vectors have become a popular alternative for some therapies because they can deliver larger gene sequences into target cells and are less likely to stimulate an immune response in the patient that could affect their safety and efficacy. million in Europe.

Immunity 52

Immunity Immunization 52

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Immunity 52

Immunity Immunization Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. Currently, all approved CAR-T therapies are autologous, where T cells taken from patients are modified and then re-infused. AZ: Allogeneic CAR-T therapies are often described as the future of the field.

Immunity 59

Immunity Immunization 59

pharmaphorum

MARCH 27, 2022

While drugs like Blenrep and teclistamab need to be administered intermittently, CAR-Ts are complex, “one and done” therapies made from a patient’s own immune cells, with a hefty price tag to match. In the US, Abecma has a list price of around $420,00, while J&J has set its therapy a little higher at $465,000.

Labelling 91

Labelling Immunity Immunization 91

PharmaShots

MARCH 9, 2023

Birthplace: Belén was born in Almansa (Spain) Additional Information: Merck became a significant international participant in immunology, oncology, and immune oncology under her leadership of the Healthcare business. and Banco Bilbao Vizcaya Argentaria S.A LinkedIn Total experience: 16 yrs.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

European Pharmaceutical Review

JULY 11, 2022

2 spike (S) protein – the receptor-binding domain (RBD) – to the body to generate an immune response. is designed to focus the immune response on parts of RBD shared by all viruses in the Severe Acute Respiratory Syndrome (SARS)-like Betacoronavirus family. 2 is the virus that causes COVID-19.). The novel vaccine?is

Vaccines 93

Vaccines Immunity Immunization 93

Pharmaceutical Technology

JANUARY 27, 2023

The program follows the lead of Pfizer’s warranty programs for Panzyga (immune globulin intravenous) and Xalkori (crizotinib), as pharma continues to explore new types of risk sharing agreements. Cablivi stops platelets from clumping together, which prevents small clots, and can be used along with other drugs that suppress the immune system.

Documentation 52

Documentation Immunity Immunization Inpatient 52

European Pharmaceutical Review

DECEMBER 27, 2023

This is especially important due to the two unique toxicities of CAR T cells, namely CRS and the neurology toxicities that subsequently received the term immune effector cell- associated neurotoxicity syndrome (ICANS). This is in addition to its considerable price tag. References Liu D. Journal of Hematology & Oncology. 2019;12(1).

Adverse Reactions 83

Adverse Reactions Immunity Immunization Medical Schools 83

Express Pharma

SEPTEMBER 11, 2023

Karnataka Antibiotics, and Bengal Immunity, etc. Failure of government’s mantra to reduce prices and make medicines affordable The Indian government puts a price tag on essential and life-saving medicines selected under the National List of Essential Medicines, published by the National Pharmaceutical Pricing Authority (NPPI).

Generic Medicine 69

Generic Medicine Diabetes Immunity Immunization 69

RX Note

FEBRUARY 9, 2024

Human Immunodeficiency Virus (HIV) 人类免疫缺陷病毒 - A virus that attacks the body's immune system. Immunization 免疫接种 - A process by which a person becomes protected against a disease through vaccination. Rheumatoid arthritis 类风湿关节炎 - A type of arthritis where your immune system attacks the tissue lining the joints on both sides of your body.

Immunity 40

Immunity Immunization Diabetes Communication 40